急性胆管炎中紧急与择期ERCP的系统评价与荟萃分析
该研究通过系统评价和荟萃分析评估急性胆管炎患者急诊胆道引流时机对结局的影响。纳入9项观察性研究共7534例患者,结果显示48小时内紧急ERCP与较低的院内死亡率、30天死亡率、器官衰竭及更短住院时间相关。
要点
- 急性胆管炎48小时内紧急ERCP与较低院内死亡率相关(OR 0.52)。
- 48小时内ERCP组住院时间平均缩短5.56天。
- 30天死亡率和器官衰竭在紧急ERCP组呈较低趋势但未达统计学显著性。
核心结论
- 急性胆管炎患者48小时内行紧急ERCP与较低的院内死亡率、30天死亡率、器官衰竭及更短住院时间相关。
研究设计与样本
- 系统评价与荟萃分析,检索Embase和PubMed自建库至2019年4月。
- 主要荟萃分析纳入9项观察性研究共7534例患者。
- 敏感性分析合并2项人群登记研究共81893例患者数据。
主要发现
- 48小时内紧急胆道引流组院内死亡率显著更低(OR 0.52,95%CI 0.28-0.98)。
- 48小时内ERCP组住院时间平均缩短5.56天(95%CI 1.59-9.53)。
- 紧急ERCP组30天死亡率OR 0.39(95%CI 0.14-1.08),器官衰竭OR 0.69(95%CI 0.33-1.46)。
- 敏感性分析合并2项人群登记研究结果与主要结局一致。
关键数值与推荐
- 急性胆管炎约20%至30%患者需胆道引流,ERCP为首选操作。
- 主要结局为院内死亡率,次要结局为住院时间、器官衰竭和30天死亡率。
临床怎么用
- 对急性胆管炎需胆道引流的患者,应考虑在48小时内行紧急ERCP以改善结局。
局限性
- 主要分析基于观察性研究,可能存在混杂偏倚。
- 30天死亡率和器官衰竭的合并OR置信区间包含1,未达统计学显著性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Acute cholangitis is characterized by abdominal pain, fever, and jaundice. Most patients respond to medical management with intravenous hydration and antibiotics. About 20% to 30% require biliary drainage, and ERCP is the procedure of choice. We conducted a systematic review and meta-analysis to evaluate the impact of emergent biliary drainage on patient outcomes. METHODS: A comprehensive literature review was conducted by searching the Embase and PubMed databases from inception to April 2019 to identify all studies that evaluated the impact of timing of ERCP on patient outcomes. Our primary outcome was in-hospital mortality (IHM), and secondary outcomes were length of stay (LOS), organ failure, and 30-day mortality. Fixed and random effects models were used to generate pooled measures of IHM, 30-day mortality, and LOS. RESULTS: Nine observational studies involving 7534 patients were included in the primary meta-analysis. IHM was significantly lower in patients who underwent emergent biliary drainage within 48 hours (odds ratio [OR], 0.52; 95% confidence interval [CI], 0.28-0.98). As a sensitivity analysis, we pooled the data from 2 population registry studies of 81,893 patients, which yielded consistent results for the main outcomes. LOS was also significantly lower in patients who underwent ERCP within 48 hours with a mean difference of 5.56 days (95% CI, 1.59-9.53). Patients who underwent emergent ERCP also had lower odds of 30-day mortality (OR, 0.39; 95% CI, 0.14-1.08) and organ failure (OR, 0.69; 95% CI, 0.33-1.46). CONCLUSIONS: Our study reveals that performing emergent ERCP within 48 hours in patients with acute cholangitis is associated with lower IHM, 30-day mortality, organ failure, and shorter LOS.
引用
- Iqbal U, Khara HS, Hu Y, et al. Emergent versus urgent ERCP in acute cholangitis: a systematic review and meta-analysis. Gastrointest Endosc. 2019. PMID: 31628955. doi:10.1016/j.gie.2019.09.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。